Advertisement
Global  

“News neutrality by unbiased coverage”
One News Page
> >

FDA approves Amgen migraine drug, price set at $6900 per year

Reuters Thursday, 17 May 2018
(Reuters) - The U.S. Food and Drug Administration on Thursday approved Amgen Inc's drug Aimovig for the prevention of migraine headaches in adults.
0
shares
ShareTweetSavePostSend
 
Credit: Wochit - Published < > Embed
News video: New Drug Prevents Migraines Before They Start

▶ New Drug Prevents Migraines Before They Start 00:49

The FDA approved a new migraine drug on Thursday. Aimovig, known generically as erenumab, is the first drug shown to stop migraine headaches before they start. The drug would be approved for patients who have tried other drugs and found no relief. In studies, it did not entirely prevent migraines,...

You Might Like


Recent related news from verified sources

Trading in Trevena shares halted as FDA reviews company's pain treatment drug

Trading in the shares of Trevena Inc (NASDAQ:TRVN) were halted on Thursday because the US Food and Drug Administration’s is reviewing its pain drug for adult...
Proactive Investors - Business

Cannpal Animal Therapeutics director shows confidence in company’s cannabis-derived animal medications

CannPal Animal Therapeutics Ltd (ASX:CP1) director Max Johnston has demonstrated his confidence in the company’s cannabis-derived medications for animals by...
Proactive Investors - Business

AcelRx Pharmaceuticals shares soar following FDA advisory committee’s approval vote for Dsuvia

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) shares are on the rise following an approval vote from the US Food and Drug Administration advisory committee on its...
Proactive Investors - Business

Cyclopharm eyes faster market entry for Technegas following positive US FDA meeting

Cyclopharm Limited (ASX:CYC) has opened up an alternative pathway for the approval of its Technegas generator following a meeting with the United States Food and...
Proactive Investors - Business


Tweets about this


Other recent news in Health

After PAUL ALLEN Co-Founded Microsoft, He Changed Brain Science Forever'Brief Answers To The Big Questions' Is STEPHEN HAWKING's Parting Gift To Humanity
OBESITY SURGERY MAY LOWER HEART ATTACK DANGER IN DIABETICSCLIMATE CHANGE Could Make Beer Prices Double, Study Says

Recent related videos from verified sources

FDA Recently Approves New Migraine Drug That Gets Injected Monthly [Video]FDA Recently Approves New Migraine Drug That Gets Injected Monthly 01:44

CBS News correspondent Susan Elizabeth-Littlefield reports.

Credit: CBS 3 Philly - Published

New Migraine Drug Provides New Hope and Relief For Sufferers [Video]New Migraine Drug Provides New Hope and Relief For Sufferers 01:25

It is being called a breakthrough for migraine suffers. A new FDA approved treatment called Emgality.

Credit: CBS4 Miami - Published

FDA Approves 3rd Migraine Preventive Drug That Might Be Free [Video]FDA Approves 3rd Migraine Preventive Drug That Might Be Free 01:01

Pharmaceutical company Eli Lilly announced Thursday the FDA has approved its migraine preventive injection Emgality.

Credit: Newsy Studio - Published

Eli Lilly to Offer Breakthrough Migraine Drug for Free [Video]Eli Lilly to Offer Breakthrough Migraine Drug for Free 01:58

Relief for migraine suffers may, at long last, be imminent. With the FDA approving Eli Lilly's Emgality drug, Christi Shaw, president of Lilly Bio-Medicines, expounded on the drug's potential efficacy...

Credit: Cheddar Inc. - Published

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest